Ball & CO Wealth Management Inc. Gilead Sciences, Inc. Transaction History
Ball & CO Wealth Management Inc.
- $93.3 Million
- Q1 2025
A detailed history of Ball & CO Wealth Management Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Ball & CO Wealth Management Inc. holds 7,387 shares of GILD stock, worth $759,457. This represents 0.89% of its overall portfolio holdings.
Number of Shares
7,387
Previous 7,335
0.71%
Holding current value
$759,457
Previous $677,000
22.16%
% of portfolio
0.89%
Previous 0.54%
Shares
2 transactions
Others Institutions Holding GILD
# of Institutions
2,203Shares Held
992MCall Options Held
8.66MPut Options Held
9.39M-
Black Rock Inc. New York, NY121MShares$12.4 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$12.1 Billion0.25% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$7.37 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.21 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$5.96 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $129B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...